ATG-018

ATR inhibitor · Antengene Discovery Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATG-018, covering 2024-07-18 to 2024-07-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematological Malignancies [Phase 1]

See pricing